Results 301 to 310 of about 908,962 (359)

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

Early DAPT discontinuation after acute myocardial infarction: finding the optimal TARGET. [PDF]

Eur Heart J Cardiovasc Pharmacother
Pyrpyris N, Dimitriadis K, Calabrò P, Gragnano F.   +3 more
europepmc   +1 more source

Socio‐economic inequalities and heart failure morbidity and mortality: A systematic review and data synthesis

ESC Heart Failure, Volume 12, Issue 2, Page 927-941, April 2025.
Abstract Socio‐economic status (SES) has been associated with incident and prevalent heart failure (HF), as well as its morbidity and mortality. However, the precise nature of the relationship between SES and HF remains unclear due to inconsistent data. This study aims to provide a comprehensive assessment and data synthesis of the relationship between
Abdul Shakoor, Willemijn A. van Maarschalkerwaart, Jeroen Schaap, Rudolf A. de Boer, Nicolas M. van Mieghem, Eric H. Boersma, Loek van Heerebeek, Jasper J. Brugts, Robert M.A. van der Boon   +8 more
wiley   +1 more source

'Tis the season for cardiometabolic thinking: a Fellow's Voice. [PDF]

Am J Prev Cardiol
Jelwan Y.
europepmc   +1 more source

Paediatric Cardiology: Its Current Practice.

, 1988
Francisco Fuentes
openalex   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Bridging the gaps in interventional cardiology disparities-socioeconomic, geographic, and political inequalities. [PDF]

Eur Heart J Open
Kaluzna-Oleksy M, Massiero G, De Rosa S, Bujak M, Hammami R, Kadri O, Kovacevic M, de Rocha RC, Leiva Pons JL, Morice MC, Chieffo A.   +10 more
europepmc   +1 more source

Society of Cardiology of the Russian Federation, National Atherosclerosis Society, Russian Society of Cardio-somatic Rehabilitation and Secondary Prevention Expert Consensus on Statin Therapy Optimization in Clinical Practice

, 2011
article Editorial
openalex   +1 more source

An unusual case of primary coronary angioplasty using the right humeral artery as a rescue vascular access: a case report and literature review. [PDF]

Oxf Med Case Reports
Sarsari M, Kerrouani O, M'ghari A, Nafii O, Aboueddahab C, Kihoul O, Zarzur J, Cherti M.   +7 more
europepmc   +1 more source

Dabigatran-based versus warfarin-based triple antithrombotic regimen with a 1-month intensification after coronary stenting in patients with nonvalvular atrial fibrillation (COACH-AF PCI). [PDF]

BMC Med
Liang M, Jin J, Zhao R, Li H, Chen S, Liu L, Xu P, Wang W, Cheng X, Chen X, Tao L, Zhang Q, Yang M, Zeng C, Li L, Zheng Y, Chen H, Guo J, Zhong Z, Bi Y, Cheng B, Zhou Y, Wang H, Zhang Y, Qiu M, Zhang Q, Zhang P, Zhang J, Wang Z, Li Y, Han Y.   +30 more
europepmc   +1 more source